MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Holmes Tremor : contribution of Botulinum toxin injection strategy guided by electromyographic (EMG) polygraphic recording

    F. Jomier, Y. Beaugendre Ahmar, E. Apartis, D. Grabli (Paris, France)

    Objective: To show that botulinum toxin injections guided by EMG polygraphic recording is effective to improve  proximal upper limbs tremor. Background: Holmes tremor is highly disabling,…
  • 2019 International Congress

    Improvement of Essential Tremor after Cortical Cerebral Infarction

    D. Riley (Warrensville Heights, OH, USA)

    Objective: To report a case of resolution of contralateral essential tremor (ET) after a cerebral cortical infarction. The restricted nature of the clinical and radiologic findings…
  • 2019 International Congress

    Tremoroton, a new open source tool for tremor analysis

    F. Vial, P. Kassavetis, M. Hallett (Bethesda, MD, USA)

    Objective: To introduce an open source software for the electrophysiological analysis of tremor. Background: The last MDS consensus on tremor in 2018 proposed a tremor…
  • 2019 International Congress

    Long-Term Outcomes with Valbenazine 40 mg/day in Adults with Tardive Dyskinesia

    S. Marder, C. Comella, C. Singer, C. Chepke, J. Burke, K. Farahmand, S. Siegert (Los Angeles, CA, USA)

    Objective: To examine long-term outcomes in adults with tardive dyskinesia (TD) who received once-daily valbenazine (VBZ) 40 mg or had a dose reduction from 80…
  • 2019 International Congress

    Subthalamic Nucleus of Luys: A review. What has evolved since 1865?

    G. Froehner, A. Meira, F. Germiniani, M. Meneses, R. Munhoz, H. Teive (Curitiba, Brazil)

    Objective: The review provides detailed material about the Subthalamic Nucleus of Luys, including pathophisiolgy, hystorical notes about Luys, embryology, anatomy, principal afferents and efferents pathways, as…
  • 2019 International Congress

    The effect of dopaminergic therapy on functional connectivity in patients with Parkinson’s disease and visual hallucinations

    A. Powell, J. Shine, S. Lewis (Sydney, Australia)

    Objective: To examine changes in functional connectivity in patients with Parkinson’s disease (PD) and visual hallucinations (VH) on and off dopaminergic medication. Background: Symptoms on…
  • 2019 International Congress

    Autonomic dysfunction in early Parkinson’s disease: a prospective study

    I. Stankovic, I. Petrovic, T. Pekmezovic, V. Markovic, T. Stojkovic, N. Dragasevic Miskovic, M. Svetel, V. Kostic (Belgrade, Serbia)

    Objective: To define prevalence, severity, and predictors of dysautonomia symptoms in patients with Parkinson's disease (PD) recruited at the Hoehn and Yahr stage 1 prospectively followed for three years.…
  • 2019 International Congress

    Cognitive and psychiatric course in the initial lustrum of Parkinson disease: the glass is half full

    D. Weintraub, C. Caspell-Garcia, H. Cho, T. Simuni, A. Siderowf, C. Coffey, D. Aarsland, R. Alcalay, L. Chahine, J. Eberling, A. Espay, J. Hamilton, J. Leverenz, I. Litvan, I. Richard, L. Rosenthal, M. York (Philadelphia, PA, USA)

    Objective: To describe the cognitive-psychiatric course in the first 5 years of diagnosed Parkinson disease (PD). Background: Although common, little is known about the differential…
  • 2019 International Congress

    Applicability of short form of Montreal Cognitive Assessment to Brazilian Portuguese

    M. Olchik, C. Rieder, L. Scudeiro, R. Millette, R. Rech, A. Ayres (Porto Alegre, Brazil)

    Objective: The aim of this study was to compare the efficiency  of the short form of Montreal Cognitive Assessment (s-MoCa) which has been validated in…
  • 2019 International Congress

    Resting-state EEG spectral power in Parkinson’s disease

    J. Dalrymple-Alford, R. Shoorangiz, E. Petersen, R. Jones, B. Elias, L. Livingston, I. Kirk, L. Tippett, M. Livingstone, T. Anderson (Christchurch, New Zealand)

    Objective: To examine the relationship between spectral power of resting state EEG (rsEEG) and cognition in Parkinson’s disease (PD). Background: Alzheimer patients have reduced rsEEG…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley